Df Dent & CO Inc Edwards Lifesciences Corp Transaction History

Df Dent & CO Inc

$7.62 Billion
Q3 2024

A detailed history of Df Dent & CO Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Df Dent & CO Inc holds 543,873 shares of EW stock, worth $36.9 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

543,873

Previous 653,203 16.74%

Holding current value

$36.9 Million

Previous $60.3 Million 40.52%

% of portfolio

0.47%

Previous 0.85%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $6.53 Million - $10.3 Million	-109,330 Reduced 16.74%	543,873 $35.9 Million
Q2 2024 Aug 14, 2024	SELL	$84.3 - $94.31 $2.03 Million - $2.27 Million	-24,111 Reduced 3.56%	653,203 $60.3 Million
Q1 2024 May 15, 2024	BUY	$72.54 - $95.56 $273,693 - $360,547	3,773 Added 0.56%	677,314 $64.7 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $13.7 Million - $17.3 Million	221,867 Added 49.12%	673,541 $51.4 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $1.72 Million - $1.99 Million	-21,069 Reduced 4.46%	451,674 $42.6 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $270,157 - $307,447	-3,638 Reduced 0.76%	472,743 $39.1 Million
Q4 2022 Feb 15, 2023	BUY	$68.3 - $87.44 $30.2 Million - $38.6 Million	441,702 Added 1273.69%	476,381 $35.5 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $69,932 - $91,089	-849 Reduced 2.39%	34,679 $2.87 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $28,545 - $42,329	330 Added 0.94%	35,528 $3.38 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $3,722 - $4,573	35 Added 0.1%	35,198 $4.56 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $5,145 - $6,137	-50 Reduced 0.14%	35,163 $3.98 Million
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $5,030 - $6,285	-60 Reduced 0.17%	35,213 $3.65 Million
Q1 2021 May 17, 2021	BUY	$78.68 - $90.67 $63,730 - $73,442	810 Added 2.35%	35,273 $2.95 Million
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $24,524 - $31,915	365 Added 1.07%	34,463 $2.75 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $1.31 Million - $1.75 Million	22,732 Added 200.0%	34,098 $2.36 Million
Q1 2020 May 15, 2020	BUY	$52.41 - $81.0 $8,909 - $13,770	170 Added 1.52%	11,366 $2.14 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $136,230 - $155,971	-1,900 Reduced 14.51%	11,196 $2.61 Million
Q1 2019 May 15, 2019	SELL	$47.89 - $64.05 $85,483 - $114,329	-1,785 Reduced 12.0%	13,096 $2.51 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $9,282 - $11,388	-200 Reduced 1.33%	14,881 $2.28 Million
Q3 2018 Nov 15, 2018	BUY	$45.7 - $58.03 $76,547 - $97,200	1,675 Added 12.49%	15,081 $2.63 Million
Q4 2017 Feb 15, 2018	SELL	$33.79 - $39.39 $844 - $984	-25 Reduced 0.19%	13,406 $1.51 Million
Q3 2017 Nov 15, 2017	BUY	$36.29 - $38.83 $487,410 - $521,525	13,431	13,431 $1.47 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Df Dent & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Df Dent & CO Inc with notifications on news.

Account